Anxiety Disorders Program, Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Braz J Psychiatry. 2010 Mar;32(1):20-9. doi: 10.1590/s1516-44462010000100006.
Recent factor-analytic studies of obsessive-compulsive disorder identified consistent symptom dimensions. This study was designed in order to observe which obsessive compulsive symptom dimensions could be changed by adding two individual sessions of motivational interviewing and thought mapping of cognitive-behavioral group therapy using a randomized clinical trial.
Forty outpatients with a primary diagnosis of obsessive-compulsive disorder were randomly assigned to receive cognitive-behavioral group therapy (control group) or motivational interviewing+thought mapping plus cognitive-behavioral group therapy. To evaluate changes in symptom dimensions, the Dimensional Yale-Brown Obsessive-Compulsive Scale was administered at baseline and after treatment.
At post-treatment, there were statistically significant differences between cognitive-behavioral group therapy and motivational interviewing+thought mapping+cognitive behavioral group therapy groups in the mean total Dimensional Yale-Brown Obsessive-Compulsive Scale score, and in the contamination and aggression dimension score. Hoarding showed a statistical trend towards improvement.
These findings suggest that adding motivational interviewing+thought mapping to cognitive-behavioral group therapy can facilitate changes and bring about a decrease in the scores in different obsessive-compulsive disorder symptom dimensions, as measured by the Dimensional Yale-Brown Obsessive-Compulsive Scale. Nonetheless, additional trials are needed to confirm these results.
最近对强迫症的因子分析研究确定了一致的症状维度。本研究旨在观察通过在认知行为团体治疗中添加两次个体动机访谈和思维映射，是否可以改变哪些强迫症症状维度，采用随机临床试验。
40 名强迫症的首发患者被随机分配到认知行为团体治疗（对照组）或动机访谈+思维映射+认知行为团体治疗组。为了评估症状维度的变化，在基线和治疗后使用耶鲁布朗强迫症量表维度版进行评估。
治疗后，认知行为团体治疗组和动机访谈+思维映射+认知行为团体治疗组之间在耶鲁布朗强迫症量表维度总分、污染和攻击维度评分方面有统计学显著差异，囤积表现出改善的统计学趋势。
这些发现表明，在认知行为团体治疗中添加动机访谈+思维映射可以促进变化，并且可以通过耶鲁布朗强迫症量表维度版测量，降低不同强迫症症状维度的评分。但是，需要进一步的试验来证实这些结果。
